For Weight Loss (Saxenda) Approved for adults with: BMI 30 (obesity) BMI 27 (overweight) + weight-related conditions (e } Liraglutide vs Other GLP-1 Agonists Liraglutide was one of the first GLP-1 drugs, but now there are newer options like semaglutide ( Wegovy , Ozempic )
Mechanism Ipamorelin selectively activates the ghrelin receptor on pituitary somatotrophs, producing a brief pulse of growth hormone release without significant activation of ACTH, cortisol, prolactin, FSH, LH, or TSH pathways distinguishing it from earlier GHRPs (GHRP-2, GHRP-6) which show off-target endocrine effects
This in turn improved the management of blood sugars and reduced their risk of the complications that occur with high blood sugars
doi: 10.1210/endo-124-1-167 30 Garcia-VelloP.TytgatH
The benefit of SGLT2i therapy beyond improved glycaemic control was first reported in the EMPA-REG study which reported a reduced incidence of major adverse cardiovascular events in patients with type 2 diabetes [19]
Selectivity is the central feature that sets ipamorelin apart from older secretagogues
